Agile Therapeutics Inc (OP: AGRX )

1.510 UNCHANGED

Streaming Delayed Price Updated: 3:34 PM EDT, Aug 23, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	253,367
Open	1.510
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	1.510
Today's Range	1.500 - 1.515
52wk Range	0.2000 - 1.520
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

AGRX Stock Earnings: Agile Therapeutics Reported Results for Q2 2024

August 13, 2024

Agile Therapeutics just reported results for the second quarter of 2024.

Via InvestorPlace

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENV, SPR, UMBF, AGRX on Behalf of Shareholders

July 15, 2024

From Halper Sadeh LLC

Via GlobeNewswire

Performance

YTD	+352.10%	+352.10%
1 Month	+5.59%	+5.59%
3 Month	+302.77%	+302.77%
6 Month	+352.10%	+352.10%
1 Year	+352.10%	+352.10%

More News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INFN, SPR, AGRX, GRDI on Behalf of Shareholders

July 02, 2024

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SHCR, AGRX on Behalf of Shareholders

June 29, 2024

From Halper Sadeh LLC

Via GlobeNewswire

AGILE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Agile Therapeutics, Inc. - AGRX

June 28, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

AGRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Agile Therapeutics, Inc. Is Fair to Shareholders

June 26, 2024

From Halper Sadeh LLC

Via Business Wire

Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.

June 26, 2024

From Agile Therapeutics, Inc.

Via GlobeNewswire

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.